BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34374294)

  • 1. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway.
    Lin QY; Qi QL; Hou S; Chen Z; Jiang N; Zhang L; Lin CH
    Neoplasma; 2021 Sep; 68(5):1063-1071. PubMed ID: 34374294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
    Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
    Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
    Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J
    Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
    Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
    Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.
    Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX
    Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
    Wu Y; Chen W; Zhang B; Liu H
    Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin - Wnt/β-catenin crosstalk.
    Donmez C; Konac E
    Gene; 2022 Aug; 836():146680. PubMed ID: 35738443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer.
    Lv J; Feng ZP; Chen FK; Liu C; Jia L; Liu PJ; Yang CZ; Hou F; Deng ZY
    Mol Carcinog; 2021 Jan; 60(1):25-37. PubMed ID: 33283877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway.
    Ye R; Liu D; Guan H; AiErken N; Fang Z; Shi Y; Zhang Y; Wang S
    Life Sci; 2021 Dec; 286():120032. PubMed ID: 34627772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBBP4 promotes colon cancer malignant progression
    Li YD; Lv Z; Zhu WF
    World J Gastroenterol; 2020 Sep; 26(35):5328-5342. PubMed ID: 32994691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.